MA31507B1 - Solutions pharmaceutiques orales contenant de la telbivudine - Google Patents
Solutions pharmaceutiques orales contenant de la telbivudineInfo
- Publication number
- MA31507B1 MA31507B1 MA32485A MA32485A MA31507B1 MA 31507 B1 MA31507 B1 MA 31507B1 MA 32485 A MA32485 A MA 32485A MA 32485 A MA32485 A MA 32485A MA 31507 B1 MA31507 B1 MA 31507B1
- Authority
- MA
- Morocco
- Prior art keywords
- tilpifudine
- oral medication
- solutions contain
- medication solutions
- thymidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention porte sur une solution pharmaceutique, appropriée pour une administration orale, qui comporte de la ß-l-thymidine/2'-désoxy-l-thymidine (telbivudine), un système de solvant approprié du point de vue pharmaceutique, un ou plusieurs agents exhausteurs de goût/de masquage du goût, un système de conservateur et un système de tampon approprié pour permettre à la fois la stabilité et la conservation de médicament.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07112381 | 2007-07-12 | ||
PCT/EP2008/059016 WO2009007426A1 (fr) | 2007-07-12 | 2008-07-10 | Solutions pharmaceutiques orales contenant de la telbivudine |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31507B1 true MA31507B1 (fr) | 2010-07-01 |
Family
ID=38724394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32485A MA31507B1 (fr) | 2007-07-12 | 2010-01-07 | Solutions pharmaceutiques orales contenant de la telbivudine |
Country Status (22)
Country | Link |
---|---|
US (1) | US8445457B2 (fr) |
EP (1) | EP2178503A1 (fr) |
JP (1) | JP5314014B2 (fr) |
KR (3) | KR20100029829A (fr) |
CN (1) | CN101686938B (fr) |
AR (1) | AR067630A1 (fr) |
AU (1) | AU2008274170B2 (fr) |
BR (1) | BRPI0815562A2 (fr) |
CA (1) | CA2693609A1 (fr) |
CL (1) | CL2008002025A1 (fr) |
CO (1) | CO6270204A2 (fr) |
EC (1) | ECSP109871A (fr) |
IL (1) | IL202961A (fr) |
MA (1) | MA31507B1 (fr) |
MY (1) | MY147366A (fr) |
NZ (1) | NZ582443A (fr) |
PE (2) | PE20130180A1 (fr) |
RU (1) | RU2493826C2 (fr) |
TN (1) | TN2010000008A1 (fr) |
TW (1) | TW200911302A (fr) |
WO (1) | WO2009007426A1 (fr) |
ZA (1) | ZA200908993B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS55582B1 (sr) | 2011-05-13 | 2017-06-30 | Array Biopharma Inc | Jedinjenja pirolidinil uree, pirolidinil tiouree i pirolidinil guanidina kao inhibitori trka kinaze |
WO2014059363A1 (fr) * | 2012-10-11 | 2014-04-17 | Antrim Pharmaceuticals Llc | Formulations de solution orale d'aripiprazole |
NZ727418A (en) | 2014-05-15 | 2023-03-31 | Array Biopharma Inc | 1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor |
EP3288562B1 (fr) * | 2015-04-26 | 2022-03-16 | MacKay Memorial Hospital | Procédé pour améliorer la fonction rénale et/ou cardiaque chez des patients atteints de maladie rénale |
CN107550866A (zh) * | 2016-06-30 | 2018-01-09 | 康普药业股份有限公司 | 一种替比夫定制剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856364A (en) | 1991-03-01 | 1999-01-05 | Warner Lambert Company | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
EP1023899A1 (fr) | 1997-09-26 | 2000-08-02 | Wakamoto Pharmaceutical Co., Ltd. | Preparation aqueuse contenant un agent antiviral a ossature purine ou pyrimidine |
DE19817265A1 (de) | 1998-04-18 | 1999-10-21 | Bayer Ag | Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe |
DE19817264A1 (de) | 1998-04-18 | 1999-10-21 | Bayer Ag | Neue Dihydropyrimidine |
AR037131A1 (es) * | 2001-10-31 | 2004-10-20 | Schering Corp | Formulaciones de jarabe de ribavirina |
TWI244393B (en) * | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
WO2006130217A2 (fr) | 2005-04-01 | 2006-12-07 | The Regents Of The University Of California | Esters de phosphate de phosphonates de nucleosides substitues |
-
2008
- 2008-07-10 NZ NZ582443A patent/NZ582443A/en not_active IP Right Cessation
- 2008-07-10 AU AU2008274170A patent/AU2008274170B2/en not_active Ceased
- 2008-07-10 PE PE2012002012A patent/PE20130180A1/es not_active Application Discontinuation
- 2008-07-10 KR KR1020107000530A patent/KR20100029829A/ko not_active Application Discontinuation
- 2008-07-10 KR KR1020127016214A patent/KR20120078754A/ko not_active Application Discontinuation
- 2008-07-10 US US12/667,975 patent/US8445457B2/en active Active
- 2008-07-10 BR BRPI0815562-3A2A patent/BRPI0815562A2/pt not_active IP Right Cessation
- 2008-07-10 MY MYPI20095510A patent/MY147366A/en unknown
- 2008-07-10 WO PCT/EP2008/059016 patent/WO2009007426A1/fr active Application Filing
- 2008-07-10 EP EP08774979A patent/EP2178503A1/fr not_active Withdrawn
- 2008-07-10 CA CA2693609A patent/CA2693609A1/fr not_active Abandoned
- 2008-07-10 JP JP2010515512A patent/JP5314014B2/ja not_active Expired - Fee Related
- 2008-07-10 PE PE2008001158A patent/PE20090476A1/es not_active Application Discontinuation
- 2008-07-10 AR ARP080102959A patent/AR067630A1/es unknown
- 2008-07-10 RU RU2010104395/15A patent/RU2493826C2/ru not_active IP Right Cessation
- 2008-07-10 CN CN2008800241250A patent/CN101686938B/zh active Active
- 2008-07-10 KR KR1020147002720A patent/KR20140019040A/ko not_active Application Discontinuation
- 2008-07-11 TW TW097126552A patent/TW200911302A/zh unknown
- 2008-07-11 CL CL2008002025A patent/CL2008002025A1/es unknown
-
2009
- 2009-12-17 ZA ZA200908993A patent/ZA200908993B/xx unknown
- 2009-12-24 IL IL202961A patent/IL202961A/en not_active IP Right Cessation
-
2010
- 2010-01-07 TN TNP2010000008A patent/TN2010000008A1/fr unknown
- 2010-01-07 MA MA32485A patent/MA31507B1/fr unknown
- 2010-01-12 CO CO10002343A patent/CO6270204A2/es active IP Right Grant
- 2010-01-12 EC EC2010009871A patent/ECSP109871A/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20130180A1 (es) | 2013-03-06 |
CO6270204A2 (es) | 2011-04-20 |
CN101686938B (zh) | 2012-09-05 |
CL2008002025A1 (es) | 2009-05-08 |
AU2008274170B2 (en) | 2011-06-09 |
AR067630A1 (es) | 2009-10-21 |
KR20100029829A (ko) | 2010-03-17 |
MY147366A (en) | 2012-11-30 |
EP2178503A1 (fr) | 2010-04-28 |
CA2693609A1 (fr) | 2009-01-15 |
CN101686938A (zh) | 2010-03-31 |
ZA200908993B (en) | 2010-09-29 |
PE20090476A1 (es) | 2009-05-12 |
IL202961A (en) | 2013-10-31 |
US8445457B2 (en) | 2013-05-21 |
WO2009007426A1 (fr) | 2009-01-15 |
JP2010533146A (ja) | 2010-10-21 |
US20100197629A1 (en) | 2010-08-05 |
JP5314014B2 (ja) | 2013-10-16 |
TW200911302A (en) | 2009-03-16 |
ECSP109871A (es) | 2010-02-26 |
TN2010000008A1 (en) | 2011-09-26 |
KR20140019040A (ko) | 2014-02-13 |
RU2493826C2 (ru) | 2013-09-27 |
RU2010104395A (ru) | 2011-08-20 |
BRPI0815562A2 (pt) | 2015-02-18 |
AU2008274170A1 (en) | 2009-01-15 |
KR20120078754A (ko) | 2012-07-10 |
NZ582443A (en) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2470016C2 (ru) | Производное бипиразола | |
AR033168A1 (es) | Solucion oral de aripiprazol | |
MA31507B1 (fr) | Solutions pharmaceutiques orales contenant de la telbivudine | |
CL2010000816A1 (es) | Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06) | |
UY27940A1 (es) | Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a | |
MA28740B1 (fr) | Methodes de traitement d'infections endobronchiques | |
AR038385A1 (es) | Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo | |
EE200300295A (et) | Kinuklidiinkarbamaadi derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud respiratoorsete, kuseelundite või mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon | |
HUP0102033A2 (hu) | PEG IFN-alfa és ribavirin felhasználása krónikus hepatitis C kezelésére | |
ATE250924T1 (de) | Cyklosporin, hyaluronsäure und polysorbate enthaltenes augenarzneimittel | |
EA200970469A1 (ru) | Антитела-агонисты рецептора trkb и их применение | |
DK1526839T3 (da) | Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed | |
BRPI0407583A (pt) | solução oftálmica lìmpida e estável | |
ATE444061T1 (de) | Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin- plasmaspiegeln | |
EA200401227A1 (ru) | Система доставки лекарства с контролируемым высвобождением, включающая правастатин | |
ATE505183T1 (de) | Den geschmack verdeckende auslaufsichere formulierung | |
WO2001047913A3 (fr) | Derives substitues d'acide n-benzyl-indol-3-yl-glyoxalique a action antitumorale | |
EE200200483A (et) | Uus iseemulgeeruv ravimi manustamise süsteem | |
CL2009000980A1 (es) | Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006). | |
BR0210650A (pt) | Tablete, e, uso do mesmo | |
ATE311928T1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
WO2005044186A3 (fr) | Formulations pharmaceutiques destinees a etre inhalees utilisant des agents dessechants et methodes d'administration desdites formulations pharmaceutiques | |
WO2007124700A3 (fr) | Composition pharmaceutique contenant un dérivé de taxane, destinée à l'élaboration d'une solution pour perfusion, sa méthode d'élaboration et ses applications | |
WO2003020214A3 (fr) | Composes derives des acides biliaires permettant d'ameliorer l'absorption orale et la biodisponibilite systemique de medicaments | |
MA27850A1 (fr) | Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate |